Unexplained weight loss

See Doctor Soon

2 studies · 1 recommendation

Last updated: February 15, 2026

Unexplained weight loss – Esophageal Cancer

See Doctor Soon2 studies

Unexplained weight loss may signal underlying esophageal cancer requiring prompt evaluation

Across 2 studies involving 1,576 participants, unexplained weight loss emerged as a clinically significant marker linked to esophageal cancer. A case-control study of 395 cases and 1,066 controls found that recent low BMI (lowest quartile) carried an OR of 1.9 (95% CI: 1.3–2.9) for squamous cell esophageal cancer, independent of smoking, alcohol, diet, and fruit/vegetable intake—pointing to weight loss as a possible early sign of carcinogenesis rather than a lifestyle factor. A retrospective cohort of 115 patients demonstrated that active skeletal muscle loss (≥2.98% decrease in muscle index) during treatment predicted significantly worse 2-year survival (p = 0.04), with 80% of patients already sarcopenic at preoperative assessment. Unexplained weight loss, particularly recent and progressive, warrants timely clinical investigation for esophageal malignancy.

Evidence

Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer : a retrospective cohort study

Authors: Ilonen, Ilkka, Järvinen, Tommi, Kauppi, Juha, Räsänen, Jari, Salo, Jarmo

Published: February 1, 2018

Among 115 esophageal cancer patients undergoing neoadjuvant therapy, a 2.98% decrease in skeletal muscle index during treatment was the threshold associated with significantly worse 2-year survival (log-rank p = 0.04). Cachexia and sarcopenia were extremely common, with 80% of patients (92/115) already sarcopenic at preoperative assessment. Median overall survival was 900 days (IQR 334-1447). The study demonstrated that it is not baseline sarcopenia status but the active loss of muscle during treatment that predicts poorer outcomes.

View Source →

Leanness and squamous cell oesophageal cancer

Authors: Franceschi, S., Gallus, S., La Vecchia, C., Levi, F., Maso, L. Dal, Simonato, L.

Published: August 2, 2017

In 395 cases and 1,066 controls, BMI one year before diagnosis in the lowest quartile was associated with an OR of 1.9 (95% CI: 1.3-2.9) for squamous cell esophageal cancer compared to the highest quartile. However, cases were not leaner than controls at age 30 (OR = 0.6 for lowest BMI quartile) or age 50 (OR = 1.1). The association with recent leanness persisted after adjusting for smoking, alcohol consumption, dietary energy intake, and fruit/vegetable consumption, suggesting that recent weight loss independent of known risk factors may reflect underlying carcinogenesis.

View Source →